A key outcome of any clinical trial is a robust data set to establish safety and efficacy, and ultimately support the launch of a commercial product. With such a focus on good data, it may be a surprise to learn that data-driven decision making is not always a focus in designing the trial, selecting vendors, and improving processes. This can have a direct on successful trial execution, and serious cost implications.
In this webinar, team members from
Fisher Clinical Services
, part of
Thermo Fisher Scientific
, will discuss key considerations in establishing and managing a successful cell therapy clinical supply chain, with an eye towards preparing for commercial launch.